World's Best Scientists 2026 revealed!
Antoine Magnan

Antoine Magnan

D-Index & Metrics

Microbiology

D-Index
63
Citations
12855
World Ranking
2765
National Ranking
166

Antoine Magnan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Antoine Magnan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 303 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Antoine Magnan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Antoine Magnan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Antoine Magnan is affiliated with the University of Nantes in France and has a substantial publication record predominantly in the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, Physiology, Surgery, Immunology, and Immunology and Allergy.

The primary research topics covered by Magnan include:

  • Asthma and respiratory diseases
  • Transplantation: Methods and Outcomes
  • Allergic Rhinitis and Sensitization
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory and Cough-Related Research
  • Eosinophilic Disorders and Syndromes
  • Dermatology and Skin Diseases

Magnan has contributed extensively to several prominent publication venues, including:

  • Revue des Maladies Respiratoires
  • Revue des Maladies Respiratoires Actualités
  • Revue française d'allergologie
  • Frontiers in Immunology
  • Allergy

Notable recent papers authored or co-authored by Magnan encompass:

  • "Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial," 2020, The Lancet Respiratory Medicine
  • "Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study," 2023, The Lancet Respiratory Medicine
  • "Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus," 2020, Journal of Thoracic Oncology
  • "Immunoglobulin E response in health and disease beyond allergic disorders," 2022, Allergy
  • "How can we minimise the use of regular oral corticosteroids in asthma?," 2020, European Respiratory Review

The scientist's frequent co-authors include:

  • Antoine Roux
  • Dorian Hassoun
  • Jérôme Le Pavec
  • Matthieu Glorion
  • Adrien Tissot

Best Publications

  • Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD

    Federico Lavorini;Antoine Magnan;Antoine Magnan;Jean Christophe Dubus;Thomas Voshaar

  • Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.

    Geoffrey L Chupp;Eric S Bradford;Frank C Albers;Daniel J Bratton

  • IL-17 in severe asthma. Where do we stand?

    Julie Chesné;Faouzi Braza;Guillaume Mahay;Sophie Brouard

  • The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement Team

    G.K. Crompton;P.J. Barnes;M. Broeders;C. Corrigan

  • Importance of inhaler devices in the management of airway disease

    J.C. Virchow;G.K. Crompton;R. Dal Negro;S. Pedersen

  • Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.

    M Humbert;G Monti;M Fartoukh;A Magnan

  • Allergic vs nonallergic asthma: what makes the difference?

    Stéphanie Romanet-Manent;D Charpin;A Magnan;A Lanteaume

  • Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

    Antoine O. Magnan;Laurent G. Mély;Christophe A. Camilla;Monique M. Badier

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype

    Mallory Pain;Olga Bermudez;Olga Bermudez;Philippe Lacoste;Philippe Lacoste;Pierre-Joseph Royer;Pierre-Joseph Royer

  • A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma

    Gilles Garcia;Gilles Garcia;Antoine Magnan;Antoine Magnan;Raphaël Chiron;Cécile Contin-Bordes;Cécile Contin-Bordes

  • Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.

    M. Humbert;F. De Blay;G. Garcia;A. Prud’homme

  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Jean Bousquet;Jean Bousquet;Peter W. Hellings;Ioana Agache;Flore Amat

  • Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma.

    Faouzi Braza;Faouzi Braza;Stéphanie Dirou;Virginie Forest;Virginie Forest;Vincent Sauzeau;Vincent Sauzeau

  • EAACI position statement on asthma exacerbations and severe asthma

    A. Čustović;S.L. Johnston;I.D. Pavord;M. Gaga

  • Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    Tim W Harrison;Pascal Chanez;Francesco Menzella;Giorgio Walter Canonica

  • Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.

    Anaïs Pipet;Anaïs Pipet;Karine Botturi;Karine Botturi;Domitille Pinot;Daniel Vervloet

  • Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.

    A. Magnan;J. P. Meunier;C. Saugnac;J. Gasteau

  • Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Jean Bousquet;Josep M Anto;Guido Iaccarino;Wienczyslawa Czarlewski

  • CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung

    Cyrille Mionnet;Vanessa Buatois;Vanessa Buatois;Akira Kanda;Akira Kanda;Akira Kanda;Valerie Milcent;Valerie Milcent

  • A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma

    Gilles Garcia;Antoine Magnan;Raphaël Chiron;Pierre-Olivier Girodet

Frequent Co-Authors

Sophie Brouard
Sophie Brouard University of Nantes
Marc Humbert
Marc Humbert University of Paris-Saclay
Daniel Vervloet
Daniel Vervloet Grenoble Alpes University
Pascal Demoly
Pascal Demoly University of Montpellier
Jean Bousquet
Jean Bousquet University of Montpellier
Inger Kull
Inger Kull Karolinska Institute
Adnan Custovic
Adnan Custovic Imperial College London
Piotr Kuna
Piotr Kuna Medical University of Lodz
Renaud Louis
Renaud Louis University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology but seeking alternative or complementary career paths, exploring related online degrees can open diverse opportunities. For individuals facing unique challenges, such as those wondering what is the best degree for a convicted felon, certain online programs in health sciences and allied fields offer accessible routes to professional growth.

One promising area is healthcare, where specialized roles like a functional medicine nurse practitioner combine clinical expertise with holistic care principles. This pathway requires targeted education and certification, often available through flexible online programs tailored to working professionals.

Additionally, certifications such as the CPC certification provide a gateway to careers in medical coding and billing. These roles are critical in healthcare administration, supporting accurate documentation and reimbursement processes.

For those drawn to the administrative side of health services, programs focused on health information management offer viable career options. Understanding the health information management salary and career paths can help students evaluate the benefits of pursuing this degree, which emphasizes data management, compliance, and technology in healthcare settings.

Best Scientists Citing Antoine Magnan

Trending Scientists

Recently Published Articles